439 related articles for article (PubMed ID: 37193706)
1. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Tamura T; Ito J; Uriu K; Zahradnik J; Kida I; Anraku Y; Nasser H; Shofa M; Oda Y; Lytras S; Nao N; Itakura Y; Deguchi S; Suzuki R; Wang L; Begum MM; Kita S; Yajima H; Sasaki J; Sasaki-Tabata K; Shimizu R; Tsuda M; Kosugi Y; Fujita S; Pan L; Sauter D; Yoshimatsu K; Suzuki S; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Yamamoto Y; Nagamoto T; Schreiber G; Maenaka K; ; Hashiguchi T; Ikeda T; Fukuhara T; Saito A; Tanaka S; Matsuno K; Takayama K; Sato K
Nat Commun; 2023 May; 14(1):2800. PubMed ID: 37193706
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
Xia S; Jiao F; Wang L; Yu X; Lu T; Fu Y; Huang Z; Li X; Huang J; Wang Q; Man Q; Xiong L; Jiang S; Lu L
J Med Virol; 2023 Mar; 95(3):e28641. PubMed ID: 36890632
[TBL] [Abstract][Full Text] [Related]
3. Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies: Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape.
Raisinghani N; Alshahrani M; Gupta G; Verkhivker G
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673865
[TBL] [Abstract][Full Text] [Related]
4. Balancing Functional Tradeoffs between Protein Stability and ACE2 Binding in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB Lineages: Dynamics-Based Network Models Reveal Epistatic Effects Modulating Compensatory Dynamic and Energetic Changes.
Verkhivker G; Alshahrani M; Gupta G
Viruses; 2023 May; 15(5):. PubMed ID: 37243229
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Conformational Dynamics and Systematic Characterization of Cryptic Pockets in the SARS-CoV-2 Omicron BA.2, BA.2.75 and XBB.1 Spike Complexes with the ACE2 Host Receptor: Confluence of Binding and Structural Plasticity in Mediating Networks of Conserved Allosteric Sites.
Alshahrani M; Gupta G; Xiao S; Tao P; Verkhivker G
Viruses; 2023 Oct; 15(10):. PubMed ID: 37896850
[TBL] [Abstract][Full Text] [Related]
6. Molecular Evolutionary Analyses of the Spike Protein Gene and Spike Protein in the SARS-CoV-2 Omicron Subvariants.
Nagasawa N; Kimura R; Akagawa M; Shirai T; Sada M; Okayama K; Sato-Fujimoto Y; Saito M; Kondo M; Katayama K; Ryo A; Kuroda M; Kimura H
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764181
[TBL] [Abstract][Full Text] [Related]
7. Structural evolution of SARS-CoV-2 omicron in human receptor recognition.
Zhang W; Shi K; Geng Q; Herbst M; Wang M; Huang L; Bu F; Liu B; Aihara H; Li F
J Virol; 2023 Aug; 97(8):e0082223. PubMed ID: 37578233
[TBL] [Abstract][Full Text] [Related]
8. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
Kimura I; Yamasoba D; Tamura T; Nao N; Suzuki T; Oda Y; Mitoma S; Ito J; Nasser H; Zahradnik J; Uriu K; Fujita S; Kosugi Y; Wang L; Tsuda M; Kishimoto M; Ito H; Suzuki R; Shimizu R; Begum MM; Yoshimatsu K; Kimura KT; Sasaki J; Sasaki-Tabata K; Yamamoto Y; Nagamoto T; Kanamune J; Kobiyama K; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Shirakawa K; Takaori-Kondo A; Kuramochi J; Schreiber G; Ishii KJ; ; Hashiguchi T; Ikeda T; Saito A; Fukuhara T; Tanaka S; Matsuno K; Sato K
Cell; 2022 Oct; 185(21):3992-4007.e16. PubMed ID: 36198317
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary and Phylogenetic Dynamics of SARS-CoV-2 Variants: A Genetic Comparative Study of Taiyuan and Wuhan Cities of China.
Hussain B; Wu C
Viruses; 2024 Jun; 16(6):. PubMed ID: 38932199
[TBL] [Abstract][Full Text] [Related]
10. Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.
Tamura T; Irie T; Deguchi S; Yajima H; Tsuda M; Nasser H; Mizuma K; Plianchaisuk A; Suzuki S; Uriu K; Begum MM; Shimizu R; Jonathan M; Suzuki R; Kondo T; Ito H; Kamiyama A; Yoshimatsu K; Shofa M; Hashimoto R; Anraku Y; Kimura KT; Kita S; Sasaki J; Sasaki-Tabata K; Maenaka K; Nao N; Wang L; Oda Y; ; Ikeda T; Saito A; Matsuno K; Ito J; Tanaka S; Sato K; Hashiguchi T; Takayama K; Fukuhara T
Nat Commun; 2024 Feb; 15(1):1176. PubMed ID: 38332154
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023.
Arantes I; Gomes M; Ito K; Sarafim S; Gräf T; Miyajima F; Khouri R; de Carvalho FC; de Almeida WAF; Siqueira MM; Resende PC; Naveca FG; Bello G;
Microbiol Spectr; 2024 Mar; 12(3):e0383123. PubMed ID: 38315011
[TBL] [Abstract][Full Text] [Related]
12. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants.
Wang Q; Iketani S; Li Z; Liu L; Guo Y; Huang Y; Bowen AD; Liu M; Wang M; Yu J; Valdez R; Lauring AS; Sheng Z; Wang HH; Gordon A; Liu L; Ho DD
Cell; 2023 Jan; 186(2):279-286.e8. PubMed ID: 36580913
[TBL] [Abstract][Full Text] [Related]
13. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.
Planas D; Staropoli I; Michel V; Lemoine F; Donati F; Prot M; Porrot F; Guivel-Benhassine F; Jeyarajah B; Brisebarre A; Dehan O; Avon L; Bolland WH; Hubert M; Buchrieser J; Vanhoucke T; Rosenbaum P; Veyer D; Péré H; Lina B; Trouillet-Assant S; Hocqueloux L; Prazuck T; Simon-Loriere E; Schwartz O
Nat Commun; 2024 Mar; 15(1):2254. PubMed ID: 38480689
[TBL] [Abstract][Full Text] [Related]
14. Differentiating Cell Entry Potentials of SARS-CoV-2 Omicron Subvariants on Human Lung Epithelium Cells.
Katte RH; Ao Y; Xu W; Han Y; Zhong G; Ghimire D; Florence J; Tucker TA; Lu M
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543757
[TBL] [Abstract][Full Text] [Related]
15. Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages.
Scarpa F; Sanna D; Azzena I; Casu M; Cossu P; Fiori PL; Benvenuto D; Imperia E; Giovanetti M; Ceccarelli G; Cauda R; Cassone A; Pascarella S; Ciccozzi M
J Med Virol; 2023 Mar; 95(3):e28625. PubMed ID: 36852665
[TBL] [Abstract][Full Text] [Related]
16. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.
Saito A; Tamura T; Zahradnik J; Deguchi S; Tabata K; Anraku Y; Kimura I; Ito J; Yamasoba D; Nasser H; Toyoda M; Nagata K; Uriu K; Kosugi Y; Fujita S; Shofa M; Monira Begum M; Shimizu R; Oda Y; Suzuki R; Ito H; Nao N; Wang L; Tsuda M; Yoshimatsu K; Kuramochi J; Kita S; Sasaki-Tabata K; Fukuhara H; Maenaka K; Yamamoto Y; Nagamoto T; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Ueno T; Schreiber G; Takaori-Kondo A; ; Shirakawa K; Sawa H; Irie T; Hashiguchi T; Takayama K; Matsuno K; Tanaka S; Ikeda T; Fukuhara T; Sato K
Cell Host Microbe; 2022 Nov; 30(11):1540-1555.e15. PubMed ID: 36272413
[TBL] [Abstract][Full Text] [Related]
17. Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission.
Benlarbi M; Ding S; Bélanger É; Tauzin A; Poujol R; Medjahed H; El Ferri O; Bo Y; Bourassa C; Hussin J; Fafard J; Pazgier M; Levade I; Abrams C; Côté M; Finzi A
mBio; 2024 Jul; ():e0090724. PubMed ID: 38953636
[TBL] [Abstract][Full Text] [Related]
18. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
Parums DV
Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047
[TBL] [Abstract][Full Text] [Related]
19. Virological characteristics of the SARS-CoV-2 BA.2.86 variant.
Tamura T; Mizuma K; Nasser H; Deguchi S; Padilla-Blanco M; Oda Y; Uriu K; Tolentino JEM; Tsujino S; Suzuki R; Kojima I; Nao N; Shimizu R; Wang L; Tsuda M; Jonathan M; Kosugi Y; Guo Z; Hinay AA; Putri O; Kim Y; Tanaka YL; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; ; Saito A; Ito J; Irie T; Tanaka S; Zahradnik J; Ikeda T; Takayama K; Matsuno K; Fukuhara T; Sato K
Cell Host Microbe; 2024 Feb; 32(2):170-180.e12. PubMed ID: 38280382
[TBL] [Abstract][Full Text] [Related]
20. Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tract.
Hu B; Chan JF; Liu Y; Liu H; Chen YX; Shuai H; Hu YF; Hartnoll M; Chen L; Xia Y; Hu JC; Yuen TT; Yoon C; Hou Y; Huang X; Chai Y; Zhu T; Shi J; Wang Y; He Y; Cai JP; Zhou J; Yuan S; Zhang J; Huang JD; Yuen KY; To KK; Zhang BZ; Chu H
EBioMedicine; 2024 Jan; 99():104916. PubMed ID: 38101297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
